Interval-compressed VDC/IE protocol feasibility and outcomes in 27 Ewing's sarcoma patients at a North African center
Compressed chemotherapy showed mixed results for Ewing's sarcoma patients in a small study.
This retrospective, single-institutional cohort study evaluated an interval-compressed VDC/IE protocol in 27 patients with Ewing's sarcoma t…
A small study found that a compressed chemotherapy regimen for Ewing's sarcoma had high toxicity and low survival rates.
Case report finds West Nile virus encephalitis in immunocompromised child after transfusions
Case report links West Nile virus infection to blood transfusions in Saudi Arabia
A case report with cross-sectional donor screening describes a 4-year-old Saudi girl with Ewing's sarcoma who developed WNV encephalitis aft…
A 4-year-old Saudi girl with cancer developed a serious brain infection after receiving blood transfusions, highlighting risks for vulnerabl…
Research across Epithelioid Sarcoma
Related studies from across the Epithelioid Sarcoma family.
Protocol for a systematic review and network meta-analysis of second-line soft tissue sarcoma treatments
Protocol outlines options for second-line soft tissue sarcoma treatments
This is a protocol for a systematic review and network meta-analysis. It will evaluate second-line pharmacological regimens for advanced sof…
A new protocol maps second-line drug choices for advanced soft tissue sarcoma patients previously treated with anthracyclines, noting curren…
FDA Approves Pomalyst (pomalidomide) for Multiple Myeloma and Kaposi Sarcoma
FDA approves new drug Pomalyst for multiple myeloma and Kaposi sarcoma.
The FDA approved Pomalyst (pomalidomide) for multiple myeloma in combination with dexamethasone after at least two prior therapies, and for …
The FDA approved Pomalyst (pomalidomide) for two conditions: multiple myeloma and Kaposi sarcoma. It offers a new option for patients who ha…
Post-hoc analysis suggests regional hyperthermia plus chemotherapy may improve survival in extremity soft tissue sarcoma
Adding heat to chemo may improve survival for soft-tissue sarcoma patients
This post-hoc analysis of a randomized trial examined overall survival in patients with extremity soft tissue sarcoma receiving neoadjuvant …
A post-hoc analysis of a randomized trial suggests adding regional hyperthermia to chemotherapy improved survival for patients with extremit…
mGPS associated with survival in advanced soft tissue sarcoma patients receiving trabectedin treatment in retrospective analysis
Blood Work May Predict Who Benefits From Sarcoma Drug
This retrospective cohort study evaluated 60 patients with advanced soft tissue sarcoma treated with trabectedin across multiple tertiary on…
A simple blood test score could help doctors predict how long patients live after starting a specific sarcoma treatment.
Retrospective cohort study assesses delta-NLR and baseline NLR for prognosis in soft tissue sarcoma
A Simple Blood Test Change Could Predict Survival in Sarcoma
This retrospective cohort study included 231 patients with soft tissue sarcoma.
Watching how a blood marker changes during treatment may give sarcoma patients a clearer picture of their future.
Case report describes diagnostic challenges in bilateral epithelioid sarcoma of the thigh
Imaging tests missed rare cancer in woman with thigh tumors, case report shows
A case report and literature review describes a 47-year-old woman with bilateral thigh masses where ultrasonography and MRI failed to provid…
Common scans missed a rare cancer in a woman with thigh tumors, proving that biopsies are vital when imaging results are unclear.